Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
2000 participants
OBSERVATIONAL
2018-05-30
2028-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Global Hip Dysplasia Registry
NCT04117685
Multicenter Prospective Cohort Study on Current Treatments of Legg-Calvé-Perthes Disease
NCT02040714
Slipped Capital Femoral Epiphysis Treatment
NCT03229590
High-resolution CE-MRA of Children's Hip Joint
NCT05754905
Evaluation of Aid to Diagnosis for Congenital Dysplasia of the Hip in General Practice
NCT04101903
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Arm I: Prospective from diagnosis
Patients have been enrolled and followed since diagnosis will be placed into Arm I.
Observational
All groups will undergo observational data collection. No interventions will be made to patient care.
Arm II: Prior treatment at centre
Patients who have received previous treatment and will continue to receive treatment at the participating center will be placed into Arm II.
Observational
All groups will undergo observational data collection. No interventions will be made to patient care.
Arm III: Prior treatment at outside centre
Patients who have received previous treatment at an outside center but are continuing treatment at a participating center will be placed into Arm III.
Observational
All groups will undergo observational data collection. No interventions will be made to patient care.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Observational
All groups will undergo observational data collection. No interventions will be made to patient care.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Intend to receiving follow-up at participating centre
* Less than 18 years old at time of admission
* Adequate diagnostic information and radiographic imaging (for patients previously treated for SCFE)
Exclusion Criteria
* Do not intend to receive follow-up at a participating centre
* Greater than 18 years old at time of admission
* Prior treatment for SCFE not appropriately documented
* Known or suspected underlying conditions (e.g., cerebral palsy, spina bifida, or osteogenesis imperfecta)
0 Years
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of British Columbia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kishore Mulpuri
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kishore Mulpuri, FRCSC
Role: PRINCIPAL_INVESTIGATOR
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
British Columbia Children's Hospital
Vancouver, British Columbia, Canada
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H15-03132
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.